P + L reacts to the anti-counterfeiting directive

In the course of the preparations for the counterfeit protection guideline, Paesel + Lorei became a member of Securpharm and ACS in order to be able to cover the products in their own portfolio as required. This relates to the delegated act on the EU Falsified Medicines Directive 2011/62 / EU. In addition, as a pharmaceutical logistics service provider, we have already met the technical requirements. Our team is trained and continues to develop. We are ready to upload and download the respective serialization code within the global as well as the national supply chain and thus meet our obligations as a pharmaceutical company.